Cautionary findings on acquired immunodeficiency from anti-CD20 MS therapyMay 1, 2020Multiple Sclerosis
Teriflunomide increases the likelihood of achieving NEDA in relapsing-remitting MSMarch 12, 2020Multiple Sclerosis
Age does not appear to affect efficacy of siponimod in secondary progressive MSMarch 10, 2020Multiple Sclerosis
How often do neurologists escalate MS therapy after detecting MRI activity?February 29, 2020Multiple Sclerosis
